These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25012948)

  • 1. Guidance for laboratories performing molecular pathology for cancer patients.
    Cree IA; Deans Z; Ligtenberg MJ; Normanno N; Edsjö A; Rouleau E; Solé F; Thunnissen E; Timens W; Schuuring E; Dequeker E; Murray S; Dietel M; Groenen P; Van Krieken JH; ;
    J Clin Pathol; 2014 Nov; 67(11):923-31. PubMed ID: 25012948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical considerations for modern molecular pathology.
    Vos S; van Diest PJ; Ausems MG; van Dijk MR; de Leng WW; Bredenoord AL
    J Pathol; 2018 Dec; 246(4):405-414. PubMed ID: 30125358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal.
    Ducar C; Smith D; Pinzon C; Stirewalt M; Cooper C; McElrath MJ; Hural J;
    J Immunol Methods; 2014 Jul; 409():9-20. PubMed ID: 24709391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.
    Dufraing K; Fenizia F; Torlakovic E; Wolstenholme N; Deans ZC; Rouleau E; Vyberg M; Parry S; Schuuring E; Dequeker EMC;
    Virchows Arch; 2021 Mar; 478(3):553-565. PubMed ID: 33047156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe.
    Dubbink HJ; Deans ZC; Tops BB; van Kemenade FJ; Koljenović S; van Krieken HJ; Blokx WA; Dinjens WN; Groenen PJ
    Mol Oncol; 2014 Jun; 8(4):830-9. PubMed ID: 24704265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.
    Volmar KE; Idowu MO; Souers RJ; Nakhleh RE
    Arch Pathol Lab Med; 2015 Sep; 139(9):1115-24. PubMed ID: 26317453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL).
    Todd CA; Sanchez AM; Garcia A; Denny TN; Sarzotti-Kelsoe M
    J Immunol Methods; 2014 Jul; 409():91-8. PubMed ID: 24120573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories.
    Tack V; Schuuring E; Keppens C; Hart N'; Pauwels P; van Krieken H; Dequeker EMC
    Br J Cancer; 2018 Aug; 119(5):605-614. PubMed ID: 30140047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.
    Wood ME; Kadlubek P; Pham TH; Wollins DS; Lu KH; Weitzel JN; Neuss MN; Hughes KS
    J Clin Oncol; 2014 Mar; 32(8):824-9. PubMed ID: 24493722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.
    Sanchez AM; Rountree W; Berrong M; Garcia A; Schuetz A; Cox J; Frahm N; Manak M; Sarzotti-Kelsoe M; D'Souza MP; Denny T; Ferrari G
    J Immunol Methods; 2014 Jul; 409():31-43. PubMed ID: 24685833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External quality assessment (EQA) and alternative assessment procedures (AAPs) in molecular diagnostics: findings of an international survey.
    Payne DA; Russomando G; Linder MW; Baluchova K; Ashavaid T; Steimer W; Ahmad-Nejad P;
    Clin Chem Lab Med; 2020 May; 59(2):301-306. PubMed ID: 32383687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
    Lynch HE; Sanchez AM; D'Souza MP; Rountree W; Denny TN; Kalos M; Sempowski GD
    J Immunol Methods; 2014 Jul; 409():62-71. PubMed ID: 24801479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European consensus conference for external quality assessment in molecular pathology.
    van Krieken JH; Siebers AG; Normanno N;
    Ann Oncol; 2013 Aug; 24(8):1958-63. PubMed ID: 23613479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for quality management in clinical microbiology.
    Schifman RB
    Clin Lab Med; 1995 Jun; 15(2):437-46. PubMed ID: 7671581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sense and nonsense in the process of accreditation of a pathology laboratory.
    Long-Mira E; Washetine K; Hofman P
    Virchows Arch; 2016 Jan; 468(1):43-9. PubMed ID: 26334197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the surgical pathology laboratory in the pre-analytical approach of molecular biology techniques].
    Hofman V; Ilie M; Gavric-Tanga V; Lespinet V; Mari M; Lassalle S; Butori C; Coelle C; Bordone O; Selva E; Lamy A; Sabourin JC; Hofman P
    Ann Pathol; 2010 Apr; 30(2):85-93. PubMed ID: 20451063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of participation in programs of external quality assessment in molecular diagnostic--our experience].
    Paro MM; Siftar Z; Juretić D; Flegar-Mestrić Z
    Acta Med Croatica; 2011 Sep; 65 Suppl 1():105-14. PubMed ID: 23126037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine.
    Compton CC; Robb JA; Anderson MW; Berry AB; Birdsong GG; Bloom KJ; Branton PA; Crothers JW; Cushman-Vokoun AM; Hicks DG; Khoury JD; Laser J; Marshall CB; Misialek MJ; Natale KE; Nowak JA; Olson D; Pfeifer JD; Schade A; Vance GH; Walk EE; Yohe SL
    Arch Pathol Lab Med; 2019 Nov; 143(11):1346-1363. PubMed ID: 31329478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.